Limited activity of bacterial DNA topoisomerase II inhibitors against Leishmania donovani and Trypanosoma cruzi amastigotes in vitro.
Croft
S L
SL
Wellcome Research Laboratories, Beckenham, Kent, UK.
Hogg
J
J
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D066298:In Vitro Techniques; D007893:Leishmania donovani / Q000187:drug effects*; D051379:Mice; D015363:Quinolones / Q000494:pharmacology; D059005:Topoisomerase II Inhibitors; D014349:Trypanosoma cruzi / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D015363:Quinolones; D059005:Topoisomerase II Inhibitors